vimarsana.com

Latest Breaking News On - Xellia pharmaceutials - Page 1 : vimarsana.com

Antibiotic Resistance Markets Therapeutics, by Pathogen and

Dublin, May 27, 2024 (GLOBE NEWSWIRE) The

Theravance biopharmaProcarta biosystemsAmpliphi biosciencesEligo bioscienceJohnson janssenBioversys gmbBiofilm pharmaAkthelia pharmaAbsynth biologicsXellia pharmaceutialsRedhill biopharmaPherecydes pharmaDeinobiotics deinoveQpex biopharmaAridis pharmaceuticals incContrafect corporation

Global Antibiotic Resistance Market Research Report 2023-2027: Search for Alternatives to Antibiotics Creates New Goldrush

/PRNewswire/ The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &.

United statesAkthelia pharmaXellia pharmaceutialsQpex biopharmaRedhill biopharmaBiofilm pharmaTheravance biopharmaProcarta biosystemsAbsynth biologicsEligo bioscienceLaura woodPherecydes pharmaJohnson janssenBioversys gmbDeinobiotics deinoveAmpliphi biosciences

Global Antibiotic Resistance Markets, 2023-2027: Beyond

Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) The

United statesQpex biopharmaXellia pharmaceutialsProcarta biosystemsBiofilm pharmaJohnson janssenTheravance biopharmaAbsynth biologicsBioversys gmbDeinobiotics deinoveEligo bioscienceRedhill biopharmaAkthelia pharmaPherecydes pharmaAmpliphi biosciencesCo ltd

Global Antibiotic Resistance Market Research Report 2023: The Key Large Market Opportunities in AMR & Therapeutic Technology Developments

/PRNewswire/ The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &.

United statesJohnson janssenRedhill biopharmaBiofilm pharmaProcarta biosystemsDeinobiotics deinoveXellia pharmaceutialsPherecydes pharmaAmpliphi biosciencesBioversys gmbTheravance biopharmaAbsynth biologicsEligo bioscienceLaura woodJ therapeutics incPhico therapeutics ltd

vimarsana © 2020. All Rights Reserved.